Side-by-side comparison of AI visibility scores, market position, and capabilities
Reston VA defense and aerospace (NYSE: GD) $47.7B FY2024 revenue (+12.3%); Gulfstream G800, Virginia/Columbia-class subs, Abrams tanks, $91.4B backlog competing with Lockheed and Northrop.
General Dynamics Corporation is a Reston, Virginia-based global aerospace and defense company — publicly traded on the New York Stock Exchange (NYSE: GD) as an S&P 500 Industrials component — designing, building, and delivering high-performance aircraft, military vehicles, nuclear submarines, and information technology services through approximately 106,000 employees worldwide. In fiscal year 2024, General Dynamics reported revenues of $47.7 billion (+12.3% year-over-year), with all four business segments contributing to growth: Aerospace (Gulfstream business jets — $12.4B, +22.8%), Marine Systems (Virginia-class and Columbia-class submarines — $14.2B, +15.1%), Combat Systems (wheeled and tracked military vehicles — $7.8B, +4.3%), and Technologies (defense IT and C4ISR — $13.3B, +7.1%). CEO Phebe Novakovic has led General Dynamics through a decade of disciplined capital allocation and backlog growth — the company's total backlog reached $91.4 billion at end of 2024, providing multi-year revenue visibility across defense contracts and Gulfstream aircraft orders. The Gulfstream G700 and G800 ultra-long-range jets entered service in 2023-2024, establishing General Dynamics's business aviation segment as the technological leader in the large-cabin corporate jet market against Bombardier and Dassault.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.